Opus Genetics, Inc.
IRD · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Magrath George: Form 4
Insider disclosure · Filed · Report period 03 Nov 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- IRD · 67577R102 - Common Stock, $0.0001 par value per share
Company details and SEC sources
CIK 0001228627 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- IRD on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 8 Davis Drive, Suite 220, Durham, NC, 27713
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
-
Ocuphire Pharma Inc. (to 22 Oct 2024) REXAHN PHARMACEUTICALS INC. (to 09 Nov 2020) CORPORATE ROAD SHOW DOT COM INC (to 29 Apr 2005) FERRARO FRANK (to 29 Apr 2003)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields